BLRX SCHEDULE 13G: SEC filing

Armistice Capital, LLC

Filed with the SEC on · accession 0001172661-26-005215

BLRX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 16, 2026. Armistice Capital, LLC filed a Schedule 13G disclosing beneficial ownership of 514,365 American Depositary Shares of BioLineRx Ltd., representing 9.99% of the class, as of September 30, 2026. The stock moved -9.2% by the first close after the filing.

Summary of the filing

Armistice Capital, LLC filed a Schedule 13G disclosing beneficial ownership of 514,365 American Depositary Shares of BioLineRx Ltd., representing 9.99% of the class, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

Key details

American Depositary Shares beneficially owned$514K
Percent of class beneficially ownedPCT 10
Reporting person / investment managerArmistice Capital, LLC
Direct holder of the reported securitiesArmistice Capital Master Fund Ltd.
IssuerBioLineRx Ltd.
Managing member of armistice capital, llcSteven Boyd

How BLRX stock reacted

Close before

$1.30

Nov 13, 2026

First close after

-9.23%

$1.18

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for BLRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BLRX?

Click here

Frequently asked questions

What did BLRX file with the SEC on Nov 16, 2026?

BLRX filed a SCHEDULE 13G (SEC filing). Armistice Capital, LLC filed a Schedule 13G disclosing beneficial ownership of 514,365 American Depositary Shares of BioLineRx Ltd., representing 9.99% of the class, as of September 30, 2026. The filing is a passive investment disclosure under Rule 13d-1(b).

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did BLRX stock react to this filing?

BLRX closed at $1.30 before the filing and $1.18 on Nov 16, 2026 (-9.23%).

Other BLRX SEC filings

Get alerts when BLRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days